Key Financial Data Of Reporting Company

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7328356

Concept As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
62,843,000,000 JPY
60,461,000,000 JPY
56,607,000,000 JPY
Operating revenue
3,716,000,000 JPY
1,732,000,000 JPY
1,371,000,000 JPY
Ordinary profit (loss)
6,522,000,000 JPY
2,467,000,000 JPY
603,000,000 JPY
5,232,000,000 JPY
717,000,000 JPY
4,880,000,000 JPY
Profit (loss)
2,466,000,000 JPY
591,000,000 JPY
682,000,000 JPY
Share capital
1,197,000,000 JPY
1,197,000,000 JPY
1,197,000,000 JPY
Total number of issued shares
30,563,199 xbrli:shares
30,563,199 xbrli:shares
30,563,199 xbrli:shares
Net assets
42,680,000,000 JPY
61,930,000,000 JPY
54,533,000,000 JPY
40,944,000,000 JPY
40,695,000,000 JPY
48,892,000,000 JPY
Total assets
43,245,000,000 JPY
90,745,000,000 JPY
87,138,000,000 JPY
41,575,000,000 JPY
41,301,000,000 JPY
83,297,000,000 JPY
Net assets per share
1,506.47
2,186.10
1,928.14
1,447.55
1,443.94
1,734.80
Dividend paid per share
40.00
16.00
15.00
Interim dividend paid per share
20.00
8.00
7.00
Basic earnings (loss) per share
266.51
87.10
20.95
150.08
23.79
151.22
Diluted earnings per share
Equity-to-asset ratio
0.987 xbrli:pure
0.6825 xbrli:pure
0.6258 xbrli:pure
0.985 xbrli:pure
0.985 xbrli:pure
0.5870 xbrli:pure
Rate of return on equity
0.1296 xbrli:pure
0.0590 xbrli:pure
0.0145 xbrli:pure
0.0820 xbrli:pure
0.0168 xbrli:pure
0.0877 xbrli:pure
Price-earnings ratio
8.33 xbrli:pure
25.48 xbrli:pure
56.76 xbrli:pure
7.92 xbrli:pure
53.10 xbrli:pure
8.35 xbrli:pure
Payout ratio
0.459 xbrli:pure
0.764 xbrli:pure
0.336 xbrli:pure
Net cash provided by (used in) operating activities
1,486,000,000 JPY
3,351,000,000 JPY
2,842,000,000 JPY
Net cash provided by (used in) investing activities
1,706,000,000 JPY
-1,126,000,000 JPY
6,743,000,000 JPY
Net cash provided by (used in) financing activities
-3,943,000,000 JPY
-1,820,000,000 JPY
-2,996,000,000 JPY
Cash and cash equivalents
16,738,000,000 JPY
17,505,000,000 JPY
17,103,000,000 JPY
Number of employees
627 xbrli:pure
15 xbrli:pure
75 xbrli:pure
762 xbrli:pure
86 xbrli:pure
75 xbrli:pure
34 xbrli:pure
747 xbrli:pure
79 xbrli:pure
74 xbrli:pure
777 xbrli:pure
Average number of temporary employees
101 xbrli:pure
1 xbrli:pure
127 xbrli:pure
19 xbrli:pure
6 xbrli:pure
117 xbrli:pure
101 xbrli:pure
Total shareholder return
1.801 xbrli:pure
0.954 xbrli:pure
xbrli:pure
Total return on share price index
1.221 xbrli:pure
1.148 xbrli:pure
xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.